Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas
about
Glucagon secretion and signaling in the development of diabetesGlucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferationRegulation of glucose homeostasis by GLP-1Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell lineGastrointestinal hormones regulating appetiteMechanisms of action of glucagon-like peptide 1 in the pancreasPrevalence, predisposition and prevention of type II diabetes.Long-acting glucagon-like peptide-1 receptor agonists have direct access to and effects on pro-opiomelanocortin/cocaine- and amphetamine-stimulated transcript neurons in the mouse hypothalamusDiscovery of gastric inhibitory polypeptide and its subsequent fate: Personal reflectionsThe required beta cell research for improving treatment of type 2 diabetesGLP-1, the gut-brain, and brain-periphery axesPhysiology of proglucagon peptides: role of glucagon and GLP-1 in health and diseaseDesign and synthesis of 4-(2,4,5-trifluorophenyl)butane-1,3-diamines as dipeptidyl peptidase IV inhibitorsMechanisms of inhibition of insulin release.Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic SuccessesEpigenetic regulation of the intestinal epitheliumGlucagon-like peptide 1 interacts with ghrelin and leptin to regulate glucose metabolism and food intake through vagal afferent neuron signalingStructure-function of the glucagon receptor family of G protein-coupled receptors: the glucagon, GIP, GLP-1, and GLP-2 receptorsThe anorectic effect of GLP-1 in rats is nutrient dependentCritical role of cAMP-GEFII--Rim2 complex in incretin-potentiated insulin secretionPostprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP). Effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the ratHuman duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db/db mice.Boc5, a non-peptidic glucagon-like Peptide-1 receptor agonist, invokes sustained glycemic control and weight loss in diabetic miceThe Impact of Glucagon-Like Peptide-1 on Bone Metabolism and Its Possible Mechanisms.Encapsulated, genetically engineered cells, secreting glucagon-like peptide-1 for the treatment of non-insulin-dependent diabetes mellitus.Evaluation of intragastric vs intraperitoneal glucose tolerance tests in the evaluation of insulin resistance in a rodent model of burn injury and glucagon-like polypeptide-1 treatmentEncapsulation of 16-Hydroxycleroda-3,13-Dine-16,15-Olide in Mesoporous Silica Nanoparticles as a Natural Dipeptidyl Peptidase-4 Inhibitor Potentiated Hypoglycemia in Diabetic Mice.The human glucagon-like peptide-1 analogue liraglutide preserves pancreatic beta cells via regulation of cell kinetics and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes.Proglucagon gene expression is regulated by a cyclic AMP-dependent pathway in rat intestine.Cardiovascular and hemodynamic effects of glucagon-like peptide-1.New insights concerning the glucose-dependent insulin secretagogue action of glucagon-like peptide-1 in pancreatic beta-cells.Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine.Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2.Novel small molecule glucagon-like peptide-1 receptor agonist stimulates insulin secretion in rodents and from human islets.Effect of ezetimibe on incretin secretion in response to the intestinal absorption of a mixed meal.Incretins: clinical perspectives, relevance, and applications for the primary care physician in the treatment of patients with type 2 diabetes mellitusThe physiology of glucagon.Insulin secretion induced by glucose-dependent insulinotropic polypeptide requires phosphatidylinositol 3-kinase γ in rodent and human β-cells.
P2860
Q21129250-DABCF8DF-DB3B-4529-8F5C-9CB70033862AQ24307581-764DC582-80C9-40BC-8A83-A41306666494Q24563430-11737781-084C-4BED-A188-CA512A428FF1Q24563957-EDC0487C-F5D8-4648-A833-7577A36C3418Q24609542-404C9CBB-0356-4F4D-9D4E-F91871ED6807Q24669951-544D2A50-545E-4105-96A8-2456C52E823AQ24683764-CD2FED8F-84FA-4387-A727-423EC657D89BQ24815863-89EC9E8E-00F6-4856-92E4-F8495A3C8E32Q26749191-97E091D7-F8D7-4095-AC07-3C88D254A5F6Q26749226-87CE7923-85EB-4F9D-9E5F-0BD8917A1194Q26851305-1DADF1DE-A0BA-4A58-9BAD-329298CED5E9Q27000749-C080FDAC-CEAE-40F0-B239-7EC7EE348B9EQ27027920-1ED6E739-B438-4800-8F6D-9FE2CB087E3EQ27684616-2B6983A5-3D56-4D54-8FBB-5E7E448BD61AQ27867698-8E496B65-EC91-4625-B03C-4A6419A3103EQ28067465-168BB494-0F64-4BD8-8AC0-52AE1AAF902CQ28084849-7DC07DAF-7E74-40C6-8CD0-951103C7764FQ28084873-B24A1E5B-2777-43A6-A574-44BC41F67783Q28203273-DE85F564-E0F7-49DE-A1A0-AEF8E7BB3756Q28484398-1C1893E6-2DCD-4E21-8E50-29AB083DC7D3Q28510313-9EAE4A83-0A5E-4DFC-8014-47DE52EAECBCQ28579516-005269AA-019F-4C3C-AE91-B982C1FA20C3Q33225025-E5C57E43-1DA5-4714-97DC-02B63805B91BQ33268721-F9A2E401-9F10-4177-9290-0410E667C55EQ33358112-C0273201-77B3-429E-B559-4CD31594D366Q33627749-9EE03B94-6A5D-475F-ACA1-7FE2D59D34BDQ33692584-31AF1F6D-7912-40E4-BD0B-BFCA806BA5E8Q33741938-B8B3357A-27F7-4101-946B-19478CBEE433Q33742245-3BA1410E-78C3-428D-B9E4-6D8EA2440657Q33826388-43EAF24E-DE9C-41FB-AB36-43A1DD09696BQ33865081-395E698F-5BBB-4B27-A614-5E343BE86AFFQ33993725-A9994D81-C789-48E1-9694-6E998F98C1C1Q34037472-8B20528C-0390-4939-83C4-CCBBFA8AAD10Q34180164-D7407115-F33D-4787-84D0-0295BAD74D00Q34289440-8952F343-A1A5-44D6-BD06-DA9CF8941BCFQ34355248-8E223F28-704E-4110-A724-080D5C634AF5Q34357416-4169DCBC-78AC-4F34-A4CD-23B48AFFCE7BQ34374350-7A6CBFA6-B57C-413C-B68B-81E1AAE59782Q34419963-BBDB8CB4-F3D2-4315-BEA7-A9E03719E30DQ34509761-6AFEF509-BE4F-49CB-A095-8C8D9A7F00D0
P2860
Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Insulinotropin: glucagon-like ...... e in the perfused rat pancreas
@en
type
label
Insulinotropin: glucagon-like ...... e in the perfused rat pancreas
@en
prefLabel
Insulinotropin: glucagon-like ...... e in the perfused rat pancreas
@en
P2093
P2860
P356
P1476
Insulinotropin: glucagon-like ...... e in the perfused rat pancreas
@en
P2093
P2860
P304
P356
10.1172/JCI112855
P407
P577
1987-02-01T00:00:00Z